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Abstract
Adult height is a classic polygenic trait of high heritability (h2,0.8). More than 180 single nucleotide polymorphisms (SNPs),
identified mostly in populations of European descent, are associated with height. These variants convey modest effects and
explain ,10% of the variance in height. Discovery efforts in other populations, while limited, have revealed loci for height
not previously implicated in individuals of European ancestry. Here, we performed a meta-analysis of genome-wide
association (GWA) results for adult height in 20,427 individuals of African ancestry with replication in up to 16,436 African
Americans. We found two novel height loci (Xp22-rs12393627, P= 3.4610212 and 2p14-rs4315565, P= 1.261028). As a
group, height associations discovered in European-ancestry samples replicate in individuals of African ancestry
(P= 1.761024 for overall replication). Fine-mapping of the European height loci in African-ancestry individuals showed
an enrichment of SNPs that are associated with expression of nearby genes when compared to the index European height
SNPs (P,0.01). Our results highlight the utility of genetic studies in non-European populations to understand the etiology of
complex human diseases and traits.
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Introduction
Adult height is a classic polygenic trait of high heritability (h2,0.8)
[1,2]. A recent large meta-analysis of genome-wide association
(GWA) results for height, which included data from .180,000
individuals of European descent, identified 180 loci that associate
with variation in height [3]. The most significantly associated variants
at these loci explain approximately 10% of the variance, consistent
with the hypothesis put forward in 1918 by Fisher on the ‘‘cumulative
Mendelian factors’’, which suggested that the segregation of a large
number of genetic variants, each of small effect, is sufficient to explain
the variation in height observed in humans [4].
In parallel to the work in European-ancestry populations, GWA
studies for adult height in other ethnic groups, including Koreans,
Japanese, Africans, and African Americans have also been
performed [5–10]. The GWA scans in East Asians replicated
several of the height loci already identified in individuals of
European descent, and also found evidence for new height loci not
previously implicated in individuals of European ancestry [6,7].
The studies in Africans and African Americans were modest in size
and, although they replicated nominally some of the associations
previously found in European populations, were not well-powered
to find new population-specific height loci [8,9].
To search for novel loci for height in populations of African ancestry,
and to explore systematically the replication of previously validated
height loci, we combined GWA results for height from nine studies
totaling 20,427 individuals of African descent. We identified two novel
height loci and observed significant evidence for the replication of
European height signals in African-derived populations. In fine-
mapping of the European height loci we also identified variants that
better define the association in individuals of African ancestry and
control local gene expression in cis (cis-eQTLs), suggesting that they are
likely to be better surrogates of the biologically functional alleles.
Results/Discussion
The meta-analysis included results from nine studies: four
population-based African-American studies (ARIC (N=2,740),
CARDIA (N=699), JHS (N= 2,119), and MESA (N=1,646)),
one family-based African-American study (CFS (N= 386)),
African-American GWA study consortia of breast (AABC
(N=5,380)) and prostate cancer (AAPC (N=5,526)) and two
case-control studies of obesity (Maywood (N=743)) and hyper-
tension (Nigeria (N= 1,188)) (Materials and Methods, Text S1 and
Table S1). We tested associations between 3,310,998 genotyped or
imputed SNPs and sex-, age-, and disease status-adjusted height Z-
scores under an additive genetic model, correcting for global
admixture using principal components (PCs) as covariates, and
modeling family structure when appropriate (Text S1). Height
results for each study were scaled using genomic control, and then
combined using the inverse-variance meta-analytic method
(Text S1).
The quantile-quantile (QQ) plot suggested little departure from
the null expectation, except at the right end tail of the distribution
(Figure 1). The associations that deviate most strongly from the
null correspond to loci previously associated with height in
European populations, providing a strong validation of our
approach (Table 1). The overall inflation factor in the meta-
analysis was lGC=1.064 and results were again scaled using
genomic control, a slightly conservative approach [11].
Two genomic loci (LCORL on chromosome 4 and PPARD on
chromosome 6), previously implicated in height in European
populations [3], reached genome-wide significance in the
discovery meta-analysis (P,561028; Table 1, Figure S1 and
Table S2). We prioritized 153 SNPs with P,161025 from our
meta-analysis for in silico replication in up to 16,436 African
Americans from five additional studies (Text S1). After combining
the data in a joint analysis, 40 SNPs from 11 different
chromosomal regions reached genome-wide significance (Table 1
and Table S2), including two SNPs not previously implicated in
the regulation of height: rs12393627 on the X-chromosome and
rs4315565 on chromosome 2 (Table 1).
rs12393627 is located 3.2 kb upstream of the arylsulfatase E
(ARSE) gene on chromosome Xp22 (Figure 2a). Mutations in the
ARSE gene cause X-linked brachytelephalangic chondrodysplasia
punctata (CDPX1; OMIM #302950), a congenital disorder of
bone and cartilage development also characterized by short stature
[12]. The co-localization of human growth syndrome genes with
SNPs associated with adult height has been reported in European-
ancestry samples [3,13,14]. rs12393627 reached a P=1.461026
in the initial meta-analysis (N= 8,333; the SNP was not on the
genotyping arrays and/or could not be imputed for AABC,
AAPC, Maywood, and Nigeria), and was strongly replicated for
association with height in 13,153 African Americans (replication
P=2.661027; combined P=5.7610212) (Table 1). When consid-
ering the number of independent markers in a 1 Mb window we
found no secondary independent signals in the region conditioning
on genotype at rs12393627. We also found no significant evidence
of heterogeneity at rs12393627 between men and women
(P=0.26).
The derived A-allele (i.e. non-ancestral allele based on the
chimp genome) at rs12393627 is monomorphic in the HapMap
CEU individuals and has a frequency of 54% in the HapMap YRI
participants. We also investigated the association of rs12393627
with height in 3,487 Japanese Americans and 2,979 Latinos from
the Multiethnic Cohort (MEC) (Text S1). Whereas the marker was
monomorphic in Japanese Americans, the association between
height and rs12393627 was replicated in Latinos with a
comparable effect size (A-allele frequency = 97%, standardized
effect size =20.17760.088, P=0.044). The frequency of this
allele is consistent with previous estimates of ,5–10% African
ancestry among Latinos in the MEC [15]. Measures of local
Author Summary
Adult height is an ideal phenotype to improve our
understanding of the genetic architecture of complex
diseases and traits: it is easily measured and usually
available in large cohorts, relatively stable, and mostly
influenced by genetics (narrow-sense heritability of height
h2,0.8). Genome-wide association (GWA) studies in
individuals of European ancestry have identified .180
single nucleotide polymorphisms (SNPs) associated with
height. In the current study, we continued to use height as
a model polygenic trait and explored the genetic influence
in populations of African ancestry through a meta-analysis
of GWA height results from 20,809 individuals of African
descent. We identified two novel height loci not previously
found in Europeans. We also replicated the European
height signals, suggesting that many of the genetic
variants that are associated with height are shared
between individuals of European and African descent.
Finally, in fine-mapping the European height loci in
African-ancestry individuals, we found SNPs more likely
to be associated with the expression of nearby genes than
the SNPs originally found in Europeans. Thus, our results
support the utility of performing genetic studies in non-
European populations to gain insights into complex
human diseases and traits.
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ancestry (the number of European-derived chromosomes (0, 1, or
2) in each individual) were not available for the X-chromosome,
but since the marker is polymorphic only in African-derived
populations (according to HapMap phase 3 data [16]), the height
association signal defined by rs12393627 on Xp22 is likely to be
specific to these populations.
SNP rs4315565 on 2p14 (discovery P=1.561027; combined
P=1.261028) is located in intron 3 of the anthrax toxin receptor 1
(ANTXR1) gene, and 189 kb upstream of the bone morphogenetic
protein 10 (BMP10) gene (Figure 2b), a member of the TGF-b
signaling pathway. This pathway is important in normal skeletal
growth [17] and implicated in previous GWA studies of height [3].
We observed no evidence of heterogeneity by sex (P=0.34) and no
independent signals when conditioning on rs4315565 within a
1 Mb window.
The allele frequency of rs4315565 differs strongly between the
HapMap CEU and YRI samples: the derived A-allele, which is
associated with decreased height, has a frequency of 85% in CEU
and 2% in YRI, respectively (Fst = 0.701). This allele frequency
difference is consistent with recent weak positive selection acting in
individuals of European ancestry (iHS=21.668) [18], and could
indicate an association with local ancestry. In a conditional
analysis where we controlled for global ancestry using PCs as
covariates, we did observe a significant association between height
and local ancestry at the ANTXR1 locus, with an increase in the
number of European chromosomes associated with a decrease in
height (P=1.661026; N= 18,495 samples available for this
analysis) [19]. Still controlling for global ancestry with PCs,
genotypes at rs4315565 could account for the association between
local ancestry and height (P=0.22 for local ancestry conditional
on rs4315565), while the association of rs4315565 with height
diminished but remained significant in the same model
(P=4.661028 and P=0.0044, before and after conditioning on
local ancestry; N=18,495).
To investigate the relationship between rs4135565 and local
ancestry further, we considered the background on which the
rs4135565 variants were present in different individuals. In
analyses stratified by the number of African/European chromo-
somes in the region, rs4315565 was nominally associated with
height in African Americans that are homozygous (P=0.038) or
heterozygous (P=0.043) for African chromosomes (with effect size
stronger in African chromosome homozygotes) (Table 2). In 1,188
Nigerians from the discovery phase, a similar trend between height
and rs4315565 was observed (P=0.075). rs4315565 was not
significantly associated with height in African Americans that are
homozygous for European chromosomes at the locus (P=0.91),
although the sample size of this sub-group is small (N= 943)
(Table 2). More strikingly, this variant is not associated with height
in populations of European ancestry in the GIANT Consortium
(N=133,653, P=0.66) [3]. Together, these results suggest that
2p14 harbors at least one novel height-associated variant that is
strongly associated with African ancestry and is correlated with
rs4315565 in African- but not European-derived chromosomes.
Our results also indicate that rs4315565 is a better marker of the
functional variant(s) than is local ancestry or any other SNPs
represented in HapMap.
We then considered the previously known height loci. Of the
180 SNPs previously reported by the GIANT Consortium to be
associated with height in populations of European ancestry, the
effect estimates for 38 SNPs were in the same direction as the
initial report and nominally associated (P,0.05) with height in the
African-derived height meta-analysis. This number is however a
lower-bound estimate of the number of known European height
loci that replicate in individuals of African ancestry because it does
not take into account different LD relationships in European and
African chromosomes: since any of the SNPs in LD in European-
ancestry individuals with the GIANT height SNPs could be causal,
this entire set of SNPs need to be evaluated, both in terms of
statistical significance and direction of effect, for replication in the
African height meta-analysis. To address this issue, we utilized a
rigorous framework, described in the Materials and Methods
section and graphically summarized in Figure S2, to test
Figure 1. Quantile–quantile (QQ) plot of the meta-analysis with up to 3.3 M SNPs across 9 studies (N=20,427). Each black circle
represents an observed statistic for genotyped SNPs only (defined as the 2log10P) against the corresponding expected statistic. The grey area
corresponds to the 90% confidence intervals calculated empirically using permutations. The individual studies’ inflation factors, as well as the inflation
factor of the meta-analysis, were corrected using genomic control. The inflation factor of the meta-analysis is lGC = 1.064.
doi:10.1371/journal.pgen.1002298.g001
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Figure 2. SNPs are plotted using LocusZoom [22] by position on the chromosome against association with adult height (2log10 P).
The SNP name shown on the plot was the most significant SNP after the discovery meta-analysis. Estimated recombination rates (from HapMap) are
plotted in cyan to reflect the local LD structure. The SNPs surrounding the most significant SNP are color coded to reflect their LD with this SNP (taken
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systematically for replication at the previously known European
height loci in the African meta-analysis. We started with 161 of the
180 height SNPs identified by the GIANT Consortium (19 SNPs
could not be tested because linkage disequilibrium (LD) informa-
tion in HapMap was not available) [3], and generated 5,819 sets of
161 SNPs matched on minor allele frequency using the
HapMap2+3 CEU dataset. We then counted the number of
SNPs (also considering LD proxies) in the African height meta-
analysis with directionally consistent (one-tailed) P#0.05 for the set
of 161 height-associated SNPs and the simulated sets. We found
one simulation with a count of nominal associations equal to or
higher than what we observed for the 161 height-associated SNPs
(P=1.761024; 171 nominal associations for the GIANT height
SNPs (and their proxies); median number of nominal associations
to height in the matched sets of SNPs= 28 (range= 8–172)).
Therefore, we found strong overall evidence of replication in our
large meta-analysis of 20,427 individuals of African ancestry for
SNPs previously associated with adult height in individuals of
European ancestry, indicating a substantial shared genetic basis for
height in populations separated since the out-of-Africa event.
The replication procedure described above also allowed us to
identify, for each of the 161 European height loci that we assessed
using data from our African meta-analysis, the best candidate
height index SNP (Table 3 and Table S3). For instance in
population of European ancestry at the LCORL locus on
chromosome 4, the GIANT height SNP (rs6449353) and the
SNP identified by fine-mapping in the African height meta-
analysis (rs7663818) are both strongly associated with height
(P,1610225) and in strong LD (r2.0.8) with each other
(Figure 3a). However, in African-derived populations, LD is
weaker between the two SNPs (r2,0.6) and the association with
height is stronger for rs7663818 (P=2.961027) than for
rs6449353 (P=0.0025) (Figure 3b). When we consider SNPs in
strong LD (r2.0.8) with rs7663818 in HapMap CEU and YRI
populations, they define genomic intervals of 250 kb and 80 kb,
respectively (light blue boxes in Figure 3). Finally, in lymphoblas-
toid cell lines derived from YRI individuals (Materials and
Methods), rs7663818, but not rs6449353, is associated with
LCORL gene expression levels (LCORL eQTL P=0.0026 and
P=0.13 for rs7663818 and rs6449353, respectively). Thus, the
LCORL locus illustrates a clear example of the utility of fine-
mapping association signals in other ethnic groups, both in terms
of narrowing the genomic interval of interest and highlighting
potential functional variants (cis-eQTL).
For 40 loci, the index SNPs from our fine-mapping list was
nominally associated with height (P,0.05) in the African height
meta-analysis, whereas the corresponding index European height
SNPs was not. To test whether this result reflects an enrichment of
surrogates for functional variants identified by fine-mapping, we
designed an experiment using allelic gene expression phenotypes
in the HapMap YRI cell lines as functional readouts. We
hypothesized that if our trans-ethnic fine-mapping strategy was
successful, a larger fraction of variants in the list of fine-mapped
height SNPs should be associated with phenotypes (in this case
gene expression) than of variants in the list of European index
height SNPs. In other words, the list of SNPs from our fine-
mapping experiment should contain more cis-eQTLs than the
GIANT list of height SNPs in cell lines derived from Africans. We
retrieved allelic expression mapping datasets from the HapMap
YRI cell lines (Materials and Methods) and observed that 4.7% of
the GIANT index height SNPs and 8.6% of the best candidate
height SNPs obtained by trans-ethnic fine-mapping, were both
nominally associated with height (P,0.05) in our meta-analysis
and with allelic expression phenotypes (P,0.01). When we used
simulations to assess the significance of these results, we found no
simulated set with a cis-eQTL enrichment equal or above that
observed in the data (P,0.01, obtained from 100 simulations
(Text S1)). Therefore, fine-mapping European height loci in
African-ancestry individuals generated a list of markers more likely
to control gene expression, potentially improving mechanistic
insights into the biology of height. Although we did not see an
enrichment when compared to the list of GIANT index height
SNPs, we also found that 17 missense SNPs are in strong LD
(r2$0.8 based on HapMap phase II YRI) with the fine-mapped
height SNPs (Table S4).
In conclusion, our study shows the benefit of performing large-
scale genetic studies in non-European populations to discover new
biology (we identified two novel height loci), and to gain functional
insights at the loci previously found in European-derived
individuals (in this case, by enrichment of cis-eQTL signals). The
strong replication of most of the European height loci in African-
ancestry populations suggest that many of the published
association signals with common variants from GWA studies –
for height and perhaps other complex diseases and traits – are
relevant across different populations and caused by shared genetic
factors that predate the out-of-Africa event.
Materials and Methods
Ethics statement
All participants gave informed written consent. The project has
been approved by the local ethics committees and/or institutional
review boards.
Studies
Five discovery studies/consortia (AABC, AAPC, CARe, May-
wood, and Nigeria) and five replication studies (GeneSTAR,
HANDLS, Health ABC, WHI, and MEC) contributed height
association results to this project. There were eight population-
based cohorts (ARIC (N=2,740), CARDIA (N=699), JHS
(N= 2119), MESA (N=1,646), HANDLS (N=993), HABC
Table 2. Stratified analysis of the association between adult
height and rs4315565 based on ancestry at the locus.
Ancestry N Beta (SE) P-value
African homozygote 11,608 20.067 (0.032) 0.038
African/European heterozygote 5,971 20.052 (0.026) 0.043
European homozygote 943 20.007 (0.056) 0.90
Combined analysis 18,522 20.051 (0.019) 0.0079
The effect size (beta) and standard error (SE) are in Z-score units. The direction
of the effect is given for the A-allele at rs4315565. Results are from a meta-
analysis of the results in ARIC, CARDIA, CFS, JHS, MESA, AABC, and AAPC.
Because of its small sample size, we could not analyze height in the CFS
participants homozygous for the European chromosome.
doi:10.1371/journal.pgen.1002298.t002
from pairwise r2 values from the ARIC African Americans Affymetrix6.0 dataset for rs1239627 (A) and from the HapMap YRI data for rs4315565 (B)).
The size of the points on the plots is proportional to the number of individuals with available genotype for any given SNP. Genes, the position of
exons and the direction of transcription from the UCSC genome browser are noted. Hashmarks represent SNP positions available in the meta-analysis.
doi:10.1371/journal.pgen.1002298.g002
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Figure 3. Height association results. In Europeans from the GIANT Consortium (A) [3] and in individuals of African ancestry (B) (this study) at the
LCORL locus on chromosome 4. The GIANT Consortium originally reported SNP rs6449353, whereas rs7663818 was fine-mapped in the African height
meta-analysis. For each panel, the light blue box corresponds to the chromosomal interval flanked by the leftmost and rightmost SNPs with a r2$0.8
with rs7663818 in HapMap CEU (A) and YRI (B) participants: these intervals are 250 kb and 80 kb wide in CEU and YRI, respectively.
doi:10.1371/journal.pgen.1002298.g003
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(N= 1,139), WHI (N= 8,149) and MEC (N=11,569)), two family-
based cohorts (CFS (N=386) and GeneSTAR (N=1,148)) two
case-control studies (Maywood (obesity, N= 743) and Nigeria
(hypertension, N= 1,188)), and two cancer consortia comprised of
case-control studies that were population-based or nested within
prospective cohorts (AABC (breast cancer, N= 5380), AAPC
(prostate cancer, N= 5,526). All cohorts with genome-wide
genotyping data available were genotyped on the Affymetrix 6.0
array, except AABC, AAPC, HANDLS, HABC and GeneSTAR,
that were genotyped on the Illumina 1M-duo or 1Mv1_c chip.
The studies, including genotyping and quality control steps, are
described in detail in Text S1. The statistics (height and age) are
summarized in Table S1. Genotype imputation was performed as
previously described [20] and is summarized in Text S1.
Statistical analysis
Height measures were corrected for sex, age, disease status, and
other appropriate covariates (e.g. recruitment centers), and were
normalized into Z-scores (Text S1). Association analysis was
performed using linear regression for studies of unrelated
individuals and a linear mixed effect model for family-based
studies, testing an additive model and including the 4–10 first
principal components. Results were combined using the inverse
variance meta-analysis method. Local ancestry was estimated
using the HAPMIX software using default parameters [19].
Conditional analyses were performed by including SNP genotypes
or local ancestry estimates in the linear models.
Replication of European height loci in African Americans
The list of European height loci from the largest study to date
was used as a source of known European loci for fine-mapping [3].
The procedure is graphically summarized in Figure S2. Of the 180
SNPs from this list, 19 were filtered for lack of available LD data
(we combined data from HapMap2 haplotype release 22 (Aug
2007), HapMap3 haplotype release 2 (Jul 2009), and HapMap2+3
LD data release 27 (Apr 2009); conflicting data, as is the case for
these 19 SNPs, were excluded). LD estimates (r2) from CEU
HapMap 2+3 were used to generate the set of common SNPs
(proxies) tagging the remaining putative loci (r2$0.8). These sets
were then binned using YRI HapMap 2+3 LD as follows: the
whole list of proxies was randomized, to remove any bias towards
significance in the representative P-values; the first SNP was
removed and set as an ‘‘index’’ SNP; then all SNPs not yet binned
were filtered based on LD (r2$0.3) with the index SNP. This
procedure was repeated until all SNPs were binned. The metric
for replication of a European signal was the number of SNP bins
nominally significant (P#0.05), and replication of the entire list of
known SNPs was the number of significant bins across all loci.
Each SNP bin was represented by the index SNP used to generate
it. Because the SNPs are in LD with known European signals,
there is a strong prediction as to which index SNP allele should be
increasing height: it should be the allele in LD with the height-
increasing allele in Europeans. Therefore, all index SNP P-values
were made one-tailed (set to P/2 or 1-P/2) based on the hypothesis
that the height-increasing allele should be the one predicted by the
European SNP, based on the phased HapMap CEU data.
The LD thresholds used for proxy determination in European
ancestry and binning in African ancestry were arbitrary and likely
do not fully encompass the LD structure of the populations in this
meta-analysis. To control for artifacts introduced by these
thresholds and the HapMap data, 5,819 sets of 161 SNPs,
matched to the European known loci on HapMap 2+3 CEU
minor allele frequency, were generated. Since the European SNP
list contains independent loci, each simulated list was designed to
contain relatively independent SNPs (CEU r2$0.2); changing this
threshold did not alter the results. The same procedure of proxy
generation and SNP binning (see Figure S2 for a graphical
description of the binning strategy) was performed on each of the
5,819 sets to generate a null distribution of significant bins.
To generate the list of ‘‘best’’ SNP for each locus (fine-mapped
list), the binning procedure was repeated for the known SNPs,
except each iteration selected an index SNP from the list of
remaining SNPs, sorted on P-value, not randomized. Note that the
best SNPs at each locus are not perfectly concordant between
Table 1 and Table 3 because our fine-mapping approach did not
consider the in silico replication data and required that the SNPs
are available in the HapMap phased haplotypes. We note that our
fine-mapping approach focuses on SNPs with low P-values and is
thus more likely to identify markers with fewer missing genotypes,
that is markers for which we have more statistical power.
Analysis of cis-acting eQTLs
To assess whether European SNPs replicated for height (at
nominal P,0.05) in African-ancestry populations would also be
more likely to show links to functional variation in samples of
African ancestry, we applied a sensitive technique for mapping cis-
regulatory allelic expression SNPs [21] in lymphoblastoid cell lines
(LCLs) derived from 56 unrelated Yoruba HapMap participants.
A detailed description of the protocols and statistical methods used
is available in the Text S1.
Supporting Information
Figure S1 Manhattan plot of the height meta-analysis
(3,310,998 SNPs in up to 20,809 participants from 9 studies).
The dashed line highlights the genome-wide significance threshold
used in this study (P,561028). In the discovery phase of the
project, SNPs at 4 loci reached genome-wide significance: LCORL
on chromosome 4, PPARD on chromosome 6, SULF1 on
chromosome 8, and ACAN on chromosome 15. The association
between height and SNPs near SULF1 did not replicate. The 3
remaining loci – LCORL, PPARD, and ACAN – are loci previously
associated with height in Europeans. Genomic-control P-values
are displayed.
(TIF)
Figure S2 On the left, an example analysis for the European
SNP rs12470505 (CCDC108). Top: rs12470505 (square) and
proxies (circles; r2$0.8 in HapMap2+3 CEU), plotted with their P-
values in the GIANT European analysis. Bottom: the same SNPs,
plotted with African-American meta-analysis P-values, converted
to one-tailed P-values based on predicted direction of effect from
the European result and phased HapMap2 CEU data. Colors
segregate SNPs into 6 randomly seeded ‘‘independent’’ clusters
(r2$0.3) using HapMap2+3 YRI linkage disequilibrium estimates.
Right: simulation results for the fine-mapping analysis. Simula-
tions were matched to the European SNP list by minor allele
frequency; SNPs in each simulation were independent of each
other at r2$0.2 in HapMap2+3 CEU. The result for each
simulation is significant bins/total bins. Red line indicates
observed proportion of significant bins for true European SNP
replication (P=8.661026).
(TIF)
Table S1 Baseline characteristics of cohorts involved in the
study.
(DOC)
Table S2 Association results for the top 153 SNPs in the
discovery meta-analysis. Positions are on NCBI build 36.1 (hg18)
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and the alleles are on the forward strand. Beta (effect size) and SE
(standard error) are in standardized ‘Z-score’ units.
(DOC)
Table S3 Fine-mapping results for SNPs associated with height
in Caucasians [49]. We could not fine-map 19 of the 180 SNPs
reported by the GIANT Consortium because they were not
available in the HapMap phased datasets. In the left-handed side
of the table, we present the association results in the African-
American height meta-analysis for SNPs associated with height in
Caucasians. In the right-handed side of the table, we present
results from our fine-mapping experiment using data from our
African-American height meta-analysis. For intergenic SNPs, we
provide the closest gene and the physical distance between them.
(DOC)
Text S1 Supplementary information.
(DOC)
Acknowledgments
The authors wish to acknowledge the contributions of the research
institutions, study investigators, field staff, and study participants.
Author Contributions
Conceived and designed the experiments: JN Hirschhorn, G Lettre, CA
Haiman. Performed the experiments: A N’Diaye, GK Chen, CD Palmer,
B Ge, V Adoue, AB Singleton, T Pastinen, JN Hirschhorn, G Lettre, CA
Haiman. Analyzed the data: A N’Diaye, GK Chen, CD Palmer, B Ge, V
Adoue, AB Singleton, T Pastinen, JN Hirschhorn, G Lettre, CA Haiman.
Contributed reagents/materials/analysis tools: A N’Diaye, GK Chen, CD
Palmer, B Ge, B Tayo, CB Ambrosone, RA Mathias, J Ding, MA Nalls, A
Adeyemo, V Adoue, L Atwood, EV Bandera, LC Becker, SI Berndt, L
Bernstein, WJ Blot, E Boerwinkle, A Britton, G Casey, SJ Chanock, E
Demerath, SL Deming, WR Diver, C Fox, TB Harris, DG Hernandez, JJ
Hu, SA Ingles, EM John, C Johnson, B Keating, RA Kittles, LN Kolonel,
SB Kritchevsky, L Le Marchand, K Lohman, J Liu, RC Millikan, A
Murphy, S Musani, C Neslund-Dudas, KE North, S Nyante, A Ogunniyi,
EA Ostrander, G Papanicolaou, S Patel, CA Pettaway, MF Press, S
Redline, JL Rodriguez-Gil, C Rotimi, BA Rybicki, B Salako, PJ Schreiner,
LB Signorello, AB Singleton, JL Stanford, AH Stram, DO Stram, SS
Strom, B Suktitipat, MJ Thun, JS Witte, LR Yanek, RG Zieger, W Zheng,
X Zhu, JM Zmuda, AB Zonderman, MK Evans, Y Liu, DM Becker, RS
Cooper, T Pastinen, BE Henderson, JN Hirschhorn, G Lettre, CA
Haiman. Wrote the paper: A N’Diaye, GK Chen, CD Palmer, T Pastinen,
JN Hirschhorn, G Lettre, CA Haiman.
References
1. Perola M, Sammalisto S, Hiekkalinna T, Martin NG, Visscher PM, et al. (2007)
Combined genome scans for body stature in 6,602 European twins: evidence
for common Caucasian loci. PLoS Genet 3: e97. doi:10.1371/journal.pgen.
0030097.
2. Visscher PM, Medland SE, Ferreira MA, Morley KI, Zhu G, et al. (2006)
Assumption-Free Estimation of Heritability from Genome-Wide Identity-by-
Descent Sharing between Full Siblings. PLoS Genet 2: e41. doi:10.1371/
journal.pgen.0020041.
3. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, et al. (2010)
Hundreds of variants clustered in genomic loci and biological pathways affect
human height. Nature 467: 832–838.
4. Fisher RA (1918) The Correlation Between Relatives on the Supposition of
Mendelian Inheritance. Transactions of the Royal Society of Edinburgh 52:
399–433.
5. Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, et al. (2009) A large-scale genome-
wide association study of Asian populations uncovers genetic factors influencing
eight quantitative traits. Nat Genet 41: 527–534.
6. Okada Y, Kamatani Y, Takahashi A, Matsuda K, Hosono N, et al. (2010) A
genome-wide association study in 19 633 Japanese subjects identified LHX3-
QSOX2 and IGF1 as adult height loci. Hum Mol Genet 19: 2303–2312.
7. Kim JJ, Lee HI, Park T, Kim K, Lee JE, et al. (2010) Identification of 15 loci
influencing height in a Korean population. J Hum Genet 55: 27–31.
8. Kang SJ, Chiang CW, Palmer CD, Tayo BO, Lettre G, et al. (2010) Genome-
wide association of anthropometric traits in African- and African-derived
populations. Hum Mol Genet 19: 2725–2738.
9. Shriner D, Adeyemo A, Gerry NP, Herbert A, Chen G, et al. (2009)
Transferability and fine-mapping of genome-wide associated loci for adult height
across human populations. PLoS ONE 4: e8398. doi:10.1371/journal.pone.
0008398.
10. Lanktree MB, Guo Y, Murtaza M, Glessner JT, Bailey SD, et al. (2011) Meta-
analysis of Dense Genecentric Association Studies Reveals Common and
Uncommon Variants Associated with Height. Am J Hum Genet 88: 6–18.
11. Yang J, Weedon MN, Purcell S, Lettre G, Estrada K, et al. (2011) Genomic
inflation factors under polygenic inheritance. Eur J Hum Genet.
12. Casarin A, Rusalen F, Doimo M, Trevisson E, Carraro S, et al. (2009) X-linked
brachytelephalangic chondrodysplasia punctata: a simple trait that is not so
simple. Am J Med Genet A 149A: 2464–2468.
13. Weedon MN, Lettre G, Freathy RM, Lindgren CM, Voight BF, et al. (2007) A
common variant of HMGA2 is associated with adult and childhood height in the
general population. Nat Genet 39: 1245–1250.
14. Sanna S, Jackson AU, Nagaraja R, Willer CJ, Chen WM, et al. (2008) Common
variants in the GDF5-UQCC region are associated with variation in human
height. Nat Genet 40: 198–203.
15. Price AL, Patterson N, Yu F, Cox DR, Waliszewska A, et al. (2007) A
genomewide admixture map for Latino populations. Am J Hum Genet 80:
1024–1036.
16. Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, et al. (2010)
Integrating common and rare genetic variation in diverse human populations.
Nature 467: 52–58.
17. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, et al. (2003)
Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan
syndrome. Nat Genet 33: 407–411.
18. Voight BF, Kudaravalli S, Wen X, Pritchard JK (2006) A map of recent positive
selection in the human genome. PLoS Biol 4: e72. doi:10.1371/journal.pbio.
0040072.
19. Price AL, Tandon A, Patterson N, Barnes KC, Rafaels N, et al. (2009) Sensitive
detection of chromosomal segments of distinct ancestry in admixed populations.
PLoS Genet 5: e1000519. doi:10.1371/journal.pgen.1000519.
20. Lettre G, Palmer CD, Young T, Ejebe KG, Allayee H, et al. (2011) Genome-
Wide Association Study of Coronary Heart Disease and Its Risk Factors in 8,090
African Americans: The NHLBI CARe Project. PLoS Genet 7: e1001300.
doi:10.1371/journal.pgen.1001300.
21. Ge B, Pokholok DK, Kwan T, Grundberg E, Morcos L, et al. (2009) Global
patterns of cis variation in human cells revealed by high-density allelic expression
analysis. Nat Genet 41: 1216–1222.
22. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, et al. (2010)
LocusZoom: regional visualization of genome-wide association scan results.
Bioinformatics 26: 2336–2337.
GWAS of Height in Individuals of African Ancestry
PLoS Genetics | www.plosgenetics.org 11 October 2011 | Volume 7 | Issue 10 | e1002298
